Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Gains from Sales and Divestitures (2016 - 2018)

Historic Gains from Sales and Divestitures for Cryo Cell International (CCEL) over the last 7 years, with Q3 2018 value amounting to $50550.0.

  • Cryo Cell International's Gains from Sales and Divestitures rose 4705.88% to $50550.0 in Q3 2018 from the same period last year, while for Aug 2018 it was $50550.0, marking a year-over-year increase of 4705.88%. This contributed to the annual value of $83238.0 for FY2017, which is 3195.4% down from last year.
  • Cryo Cell International's Gains from Sales and Divestitures amounted to $50550.0 in Q3 2018, which was up 4705.88% from $41797.0 recorded in Q2 2018.
  • Cryo Cell International's 5-year Gains from Sales and Divestitures high stood at $122326.0 for Q4 2016, and its period low was $5625.0 during Q1 2016.
  • For the 5-year period, Cryo Cell International's Gains from Sales and Divestitures averaged around $44298.3, with its median value being $34580.0 (2015).
  • As far as peak fluctuations go, Cryo Cell International's Gains from Sales and Divestitures surged by 26185.52% in 2016, and later plummeted by 6376.31% in 2017.
  • Over the past 5 years, Cryo Cell International's Gains from Sales and Divestitures (Quarter) stood at $75409.0 in 2014, then plummeted by 54.14% to $34580.0 in 2015, then surged by 253.75% to $122326.0 in 2016, then tumbled by 31.95% to $83238.0 in 2017, then crashed by 39.27% to $50550.0 in 2018.
  • Its last three reported values are $50550.0 in Q3 2018, $41797.0 for Q2 2018, and $18957.0 during Q1 2018.